We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Torrent Pharma Finds Itself in FDA’s Sights Over Nitrosamine Contamination
Torrent Pharma Finds Itself in FDA’s Sights Over Nitrosamine Contamination
The FDA named Indian drugmaker Torrent Pharmaceuticals as a target of its investigation into nitrosamine impurities and issued the company a warning letter for repeat violations at its Indrad, Gujarat plant.